These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 12673563

  • 1. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B, Ratschek M, Harms D, Jaenig U, Leuschner I, Poremba C, Hoefler G.
    Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
    [Abstract] [Full Text] [Related]

  • 2. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK, Brown KW, Berry PJ.
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P, Telzerow P, Moksness J, Breslow NE.
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [Abstract] [Full Text] [Related]

  • 4. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G, Rieske P, Bartkowiak J, Szymik-Kantorowicz S, Daszkiewicz P, Debiec-Rychter M.
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [Abstract] [Full Text] [Related]

  • 5. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
    Brown KW, Power F, Moore B, Charles AK, Malik KT.
    Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
    [Abstract] [Full Text] [Related]

  • 6. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV, Tycko B.
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [Abstract] [Full Text] [Related]

  • 7. Activation of beta-catenin is a late event in the pathogenesis of nephroblastomas and rarely correlated with genetic changes of the APC gene.
    Grill C, Sunitsch S, Hatz M, Hauser-Kronberger C, Leuschner I, Hoefler G, Guertl B.
    Pathology; 2011 Dec; 43(7):702-6. PubMed ID: 22081130
    [Abstract] [Full Text] [Related]

  • 8. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J.
    Cancer Res; 1991 Nov 01; 51(21):5937-42. PubMed ID: 1657374
    [Abstract] [Full Text] [Related]

  • 9. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM, National Wilms Tumor Study Group.
    J Clin Oncol; 2005 Oct 10; 23(29):7312-21. PubMed ID: 16129848
    [Abstract] [Full Text] [Related]

  • 10. Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes.
    Guertl B, Leuschner I, Harms D, Hoefler G.
    Virchows Arch; 2006 Aug 10; 449(2):171-4. PubMed ID: 16715229
    [Abstract] [Full Text] [Related]

  • 11. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G.
    Cancer Res; 1992 Nov 01; 52(21):6117-20. PubMed ID: 1356625
    [Abstract] [Full Text] [Related]

  • 12. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC, Hendrickson BW, Colella S, Krahe R, Pinto L, Huff V.
    Genes Chromosomes Cancer; 2005 Jun 01; 43(2):172-80. PubMed ID: 15761866
    [Abstract] [Full Text] [Related]

  • 13. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S, Bernard A, Bove KE, Sens DA, Hazen-Martin DJ, Garvin AJ, Haber DA.
    Nat Genet; 1993 Dec 01; 5(4):363-7. PubMed ID: 8298644
    [Abstract] [Full Text] [Related]

  • 14. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.
    Karnik P, Chen P, Paris M, Yeger H, Williams BR.
    Oncogene; 1998 Jul 16; 17(2):237-40. PubMed ID: 9674708
    [Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity at 7p in Wilms' tumour development.
    Powlesland RM, Charles AK, Malik KT, Reynolds PA, Pires S, Boavida M, Brown KW.
    Br J Cancer; 2000 Jan 16; 82(2):323-9. PubMed ID: 10646884
    [Abstract] [Full Text] [Related]

  • 16. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor.
    Mason JE, Goodfellow PJ, Grundy PE, Skinner MA.
    J Pediatr Surg; 2000 Jun 16; 35(6):891-6; discussion 896-7. PubMed ID: 10873032
    [Abstract] [Full Text] [Related]

  • 17. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L.
    Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC.
    Cancer Res; 1994 May 01; 54(9):2331-3. PubMed ID: 8162576
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S, Becker KF, Braungart E, Reichmuth C, Klamt B, Becker I, Atkinson M, Gessler M, Höfler H.
    J Pathol; 2000 Jun 01; 191(2):162-9. PubMed ID: 10861576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.